Last 12 months
Inside the activity.
0 purchase rows · 18 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 18, 2025 Filed Mar 20, 2025 20:15 UTC |
Williams BradPRESIDENT
|
Exercise / conversionRestricted Stock Units · Derivative | 4,508 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-026138 · tm259720-1_4seq1.xml · derivative · entry 3 Williams Brad · CIK 0001876053 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,016 Underlying: Common Stock · 4,508 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Comprised of a restricted stock units award (the "Restricted Stock Award") granted under Cadre Holdings, Inc.'s (the "Issuer") 2021 Stock Incentive Plan consisting of 13,524 shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 4,508 restricted shares of Common Stock vested and became non-forfeitable on March 18, 2025, and 4,508 restricted shares of Common Stock will vest and become non-forfeitable on each of March 18, 2026 and March 18, 2027, respectively. F1 · derivative.exercise_date: Comprised of a restricted stock units award (the "Restricted Stock Award") granted under Cadre Holdings, Inc.'s (the "Issuer") 2021 Stock Incentive Plan consisting of 13,524 shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 4,508 restricted shares of Common Stock vested and became non-forfeitable on March 18, 2025, and 4,508 restricted shares of Common Stock will vest and become non-forfeitable on each of March 18, 2026 and March 18, 2027, respectively. F1 · derivative.expiration_date: Comprised of a restricted stock units award (the "Restricted Stock Award") granted under Cadre Holdings, Inc.'s (the "Issuer") 2021 Stock Incentive Plan consisting of 13,524 shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 4,508 restricted shares of Common Stock vested and became non-forfeitable on March 18, 2025, and 4,508 restricted shares of Common Stock will vest and become non-forfeitable on each of March 18, 2026 and March 18, 2027, respectively. Read SEC document |
| March 18, 2025 Filed Mar 20, 2025 20:15 UTC |
Williams BradPRESIDENT
|
Tax withholdingCommon Stock | 1,098 | $32.33 | $35,498.34 |
DisclosureSEC source: 0001104659-25-026138 · tm259720-1_4seq1.xml · nonDerivative · entry 2 Williams Brad · CIK 0001876053 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,790 F2 · shares: Represents the number of shares of Common Stock withheld by the Issuer to satisfy the tax withholding obligations incurred by Mr. Williams as a result of the vesting, on March 18, 2025, of a portion of the Restricted Stock Award. Read SEC document |
| March 18, 2025 Filed Mar 20, 2025 20:15 UTC |
Williams BradPRESIDENT
|
Exercise / conversionCommon Stock, par value $0.0001 per share ("Common Stock") | 4,508 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-026138 · tm259720-1_4seq1.xml · nonDerivative · entry 1 Williams Brad · CIK 0001876053 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,888 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Comprised of a restricted stock units award (the "Restricted Stock Award") granted under Cadre Holdings, Inc.'s (the "Issuer") 2021 Stock Incentive Plan consisting of 13,524 shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 4,508 restricted shares of Common Stock vested and became non-forfeitable on March 18, 2025, and 4,508 restricted shares of Common Stock will vest and become non-forfeitable on each of March 18, 2026 and March 18, 2027, respectively. Read SEC document |
| March 18, 2025 Filed Mar 20, 2025 20:15 UTC |
Browers BlaineCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 3,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-026141 · tm259720-2_4seq1.xml · derivative · entry 3 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,564 Underlying: Common Stock · 3,282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Comprised of a restricted stock units award (the "Restricted Stock Award") granted under Cadre Holdings, Inc.'s (the "Issuer") 2021 Stock Incentive Plan consisting of 9,846 shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 3,282 restricted shares of Common Stock vested and became non-forfeitable on March 18, 2025, and 3,282 restricted shares of Common Stock will vest and become non-forfeitable on each of March 18, 2026 and March 18, 2027, respectively. F1 · derivative.exercise_date: Comprised of a restricted stock units award (the "Restricted Stock Award") granted under Cadre Holdings, Inc.'s (the "Issuer") 2021 Stock Incentive Plan consisting of 9,846 shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 3,282 restricted shares of Common Stock vested and became non-forfeitable on March 18, 2025, and 3,282 restricted shares of Common Stock will vest and become non-forfeitable on each of March 18, 2026 and March 18, 2027, respectively. F1 · derivative.expiration_date: Comprised of a restricted stock units award (the "Restricted Stock Award") granted under Cadre Holdings, Inc.'s (the "Issuer") 2021 Stock Incentive Plan consisting of 9,846 shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 3,282 restricted shares of Common Stock vested and became non-forfeitable on March 18, 2025, and 3,282 restricted shares of Common Stock will vest and become non-forfeitable on each of March 18, 2026 and March 18, 2027, respectively. Read SEC document |
| March 18, 2025 Filed Mar 20, 2025 20:15 UTC |
Browers BlaineCHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 800 | $32.33 | $25,864.00 |
DisclosureSEC source: 0001104659-25-026141 · tm259720-2_4seq1.xml · nonDerivative · entry 2 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,578 F2 · shares: Represents the number of shares of Common Stock withheld by the Issuer to satisfy the tax withholding obligations incurred by Mr. Browers as a result of the vesting, on March 18, 2025, of a portion of the Restricted Stock Award. Read SEC document |
| March 18, 2025 Filed Mar 20, 2025 20:15 UTC |
Browers BlaineCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock, par value $0.0001 per share ("Common Stock") | 3,282 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-026141 · tm259720-2_4seq1.xml · nonDerivative · entry 1 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,378 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Comprised of a restricted stock units award (the "Restricted Stock Award") granted under Cadre Holdings, Inc.'s (the "Issuer") 2021 Stock Incentive Plan consisting of 9,846 shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 3,282 restricted shares of Common Stock vested and became non-forfeitable on March 18, 2025, and 3,282 restricted shares of Common Stock will vest and become non-forfeitable on each of March 18, 2026 and March 18, 2027, respectively. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 20:15 UTC |
KANDERS WARREN BDirector · CEO AND CHAIRMAN · 10% owner
|
SaleCommon Stock | 100,000 | $32.38 | $3,238,000.00 |
DisclosureSEC source: 0001104659-25-025029 · tm259597-1_4seq1.xml · nonDerivative · entry 2 KANDERS WARREN B · CIK 0000935577 · Director · CEO AND CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Kanders SAF, LLC Disclosed balance after: 11,066,192 F2 · price: The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $32.03 - $33.50 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · ownership.nature: The Reporting Person is the sole manager and member of Kanders SAF, LLC. F5 · ownership.nature: The Reporting Person disclaims beneficial ownership of the securities described in this statement, except to the extent of his pecuniary interest in such securities. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 20:15 UTC |
KANDERS WARREN BDirector · CEO AND CHAIRMAN · 10% owner
|
SaleCommon Stock, par value $0.0001 per share ("Common Stock") | 100,000 | $33.86 | $3,386,000.00 |
DisclosureSEC source: 0001104659-25-025029 · tm259597-1_4seq1.xml · nonDerivative · entry 1 KANDERS WARREN B · CIK 0000935577 · Director · CEO AND CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Kanders SAF, LLC Disclosed balance after: 11,166,192 F1 · price: The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $33.05 - $35.18 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. F3 · ownership.nature: The Reporting Person is the sole manager and member of Kanders SAF, LLC. F5 · ownership.nature: The Reporting Person disclaims beneficial ownership of the securities described in this statement, except to the extent of his pecuniary interest in such securities. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:15 UTC |
KANDERS WARREN BDirector · CEO AND CHAIRMAN · 10% owner
|
GrantRestricted Stock Units · Derivative | 37,423 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-024426 · tm259280-2_4seq1.xml · derivative · entry 8 KANDERS WARREN B · CIK 0000935577 · Director · CEO AND CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,423 Underlying: Common Stock · 37,423 shares Expires not disclosed F7 · derivative.exercise_price: Comprised of a restricted stock units award granted under the Plan consisting of 37,423 restricted shares of the Issuer's Common Stock. 12,475 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2026, and 12,474 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 13, 2027, and March 13, 2028, respectively. F7 · derivative.exercise_date: Comprised of a restricted stock units award granted under the Plan consisting of 37,423 restricted shares of the Issuer's Common Stock. 12,475 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2026, and 12,474 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 13, 2027, and March 13, 2028, respectively. F7 · derivative.expiration_date: Comprised of a restricted stock units award granted under the Plan consisting of 37,423 restricted shares of the Issuer's Common Stock. 12,475 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2026, and 12,474 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 13, 2027, and March 13, 2028, respectively. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:15 UTC |
KANDERS WARREN BDirector · CEO AND CHAIRMAN · 10% owner
|
GrantStock Option (right to purchase) · Derivative | 116,865 | $0.00 Strike: $34.91 | $0.00 |
DisclosureSEC source: 0001104659-25-024426 · tm259280-2_4seq1.xml · derivative · entry 7 KANDERS WARREN B · CIK 0000935577 · Director · CEO AND CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,865 Underlying: Common Stock · 116,865 shares Expires 2035-03-13 F6 · derivative.exercise_date: The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 38,955 shares of the Issuer's Common Stock will vest and become exercisable on each of March 13, 2026, March 13, 2027, and March 13, 2028, respectively. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:15 UTC |
KANDERS WARREN BDirector · CEO AND CHAIRMAN · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 11,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-024426 · tm259280-2_4seq1.xml · derivative · entry 6 KANDERS WARREN B · CIK 0000935577 · Director · CEO AND CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,455 Underlying: Common Stock · 11,455 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Comprised of a restricted stock units award previously granted on March 13, 2023 (the "Restricted Stock Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 34,363 restricted shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 11,453 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2024, 11,455 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2025, and 11,455 restricted shares of Common Stock will vest and become non-forfeitable on March 13, 2026. F1 · derivative.exercise_date: Comprised of a restricted stock units award previously granted on March 13, 2023 (the "Restricted Stock Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 34,363 restricted shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 11,453 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2024, 11,455 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2025, and 11,455 restricted shares of Common Stock will vest and become non-forfeitable on March 13, 2026. F1 · derivative.expiration_date: Comprised of a restricted stock units award previously granted on March 13, 2023 (the "Restricted Stock Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 34,363 restricted shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 11,453 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2024, 11,455 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2025, and 11,455 restricted shares of Common Stock will vest and become non-forfeitable on March 13, 2026. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:15 UTC |
KANDERS WARREN BDirector · CEO AND CHAIRMAN · 10% owner
|
Tax withholdingCommon Stock | 2,961 | $34.91 | $103,368.51 |
DisclosureSEC source: 0001104659-25-024426 · tm259280-2_4seq1.xml · nonDerivative · entry 2 KANDERS WARREN B · CIK 0000935577 · Director · CEO AND CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,804 F2 · shares: Represents the number of shares of Common Stock withheld by the Issuer to satisfy the tax withholding obligations incurred by Mr. Kanders as a result of the vesting on March 13, 2025, of a portion of the Restricted Stock Award. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:15 UTC |
KANDERS WARREN BDirector · CEO AND CHAIRMAN · 10% owner
|
Exercise / conversionCommon Stock, par value $0.0001 per share ("Common Stock") | 11,455 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-024426 · tm259280-2_4seq1.xml · nonDerivative · entry 1 KANDERS WARREN B · CIK 0000935577 · Director · CEO AND CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Comprised of a restricted stock units award previously granted on March 13, 2023 (the "Restricted Stock Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 34,363 restricted shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 11,453 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2024, 11,455 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2025, and 11,455 restricted shares of Common Stock will vest and become non-forfeitable on March 13, 2026. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:15 UTC |
Williams BradPRESIDENT
|
GrantRestricted Stock Units · Derivative | 15,409 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-024420 · tm259280-1_4seq1.xml · derivative · entry 5 Williams Brad · CIK 0001876053 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,409 Underlying: Common Stock · 15,409 shares Expires not disclosed F4 · derivative.exercise_price: Comprised of a restricted stock units award granted under the Plan consisting of 15,409 restricted shares of the Issuer's Common Stock. 5,137 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2026, and 5,136 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 13, 2027 and March 13, 2028, respectively. F4 · derivative.exercise_date: Comprised of a restricted stock units award granted under the Plan consisting of 15,409 restricted shares of the Issuer's Common Stock. 5,137 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2026, and 5,136 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 13, 2027 and March 13, 2028, respectively. F4 · derivative.expiration_date: Comprised of a restricted stock units award granted under the Plan consisting of 15,409 restricted shares of the Issuer's Common Stock. 5,137 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2026, and 5,136 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 13, 2027 and March 13, 2028, respectively. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:15 UTC |
Williams BradPRESIDENT
|
GrantStock Option (right to purchase) · Derivative | 48,121 | $0.00 Strike: $34.91 | $0.00 |
DisclosureSEC source: 0001104659-25-024420 · tm259280-1_4seq1.xml · derivative · entry 4 Williams Brad · CIK 0001876053 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,121 Underlying: Common Stock · 48,121 shares Expires 2035-03-13 F3 · derivative.exercise_date: The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 16,041 shares of the Issuer's Common Stock will vest and become exercisable on March 13, 2026, and options to purchase 16,040 shares of the Issuer's Common Stock will vest and become exercisable on each of March 13, 2027, and March 13, 2028, respectively. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:15 UTC |
Williams BradPRESIDENT
|
Exercise / conversionRestricted Stock Units · Derivative | 4,191 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-024420 · tm259280-1_4seq1.xml · derivative · entry 3 Williams Brad · CIK 0001876053 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,191 Underlying: Common Stock · 4,191 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Comprised of a restricted stock units award previously granted on March 13, 2023 (the "Restricted Stock Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 12,572 restricted shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 4,190 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2024, 4,191 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2025, and 4,191 restricted shares of Common Stock will vest and become non-forfeitable on March 13, 2026. F1 · derivative.exercise_date: Comprised of a restricted stock units award previously granted on March 13, 2023 (the "Restricted Stock Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 12,572 restricted shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 4,190 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2024, 4,191 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2025, and 4,191 restricted shares of Common Stock will vest and become non-forfeitable on March 13, 2026. F1 · derivative.expiration_date: Comprised of a restricted stock units award previously granted on March 13, 2023 (the "Restricted Stock Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 12,572 restricted shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 4,190 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2024, 4,191 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2025, and 4,191 restricted shares of Common Stock will vest and become non-forfeitable on March 13, 2026. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:15 UTC |
Williams BradPRESIDENT
|
Tax withholdingCommon Stock | 1,021 | $34.91 | $35,643.11 |
DisclosureSEC source: 0001104659-25-024420 · tm259280-1_4seq1.xml · nonDerivative · entry 2 Williams Brad · CIK 0001876053 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,380 F2 · shares: Represents the number of shares of Common Stock withheld by the Issuer to satisfy the tax withholding obligations incurred by Mr. Williams as a result of the vesting on March 13, 2025, of a portion of the Restricted Stock Award. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:15 UTC |
Williams BradPRESIDENT
|
Exercise / conversionCommon Stock, par value $0.0001 per share ("Common Stock") | 4,191 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-024420 · tm259280-1_4seq1.xml · nonDerivative · entry 1 Williams Brad · CIK 0001876053 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Comprised of a restricted stock units award previously granted on March 13, 2023 (the "Restricted Stock Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 12,572 restricted shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 4,190 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2024, 4,191 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2025, and 4,191 restricted shares of Common Stock will vest and become non-forfeitable on March 13, 2026. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:16 UTC |
Browers BlaineCHIEF FINANCIAL OFFICER
|
GrantRestricted Stock Units · Derivative | 12,841 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-024429 · tm259280-3_4seq1.xml · derivative · entry 5 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,841 Underlying: Common Stock · 12,841 shares Expires not disclosed F4 · derivative.exercise_price: Comprised of a restricted stock units award granted under the Plan consisting of 12,841 restricted shares of the Issuer's Common Stock. 4,281 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2026, and 4,280 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 13, 2027, and March 13, 2028, respectively. F4 · derivative.exercise_date: Comprised of a restricted stock units award granted under the Plan consisting of 12,841 restricted shares of the Issuer's Common Stock. 4,281 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2026, and 4,280 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 13, 2027, and March 13, 2028, respectively. F4 · derivative.expiration_date: Comprised of a restricted stock units award granted under the Plan consisting of 12,841 restricted shares of the Issuer's Common Stock. 4,281 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2026, and 4,280 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 13, 2027, and March 13, 2028, respectively. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:16 UTC |
Browers BlaineCHIEF FINANCIAL OFFICER
|
GrantStock Option (right to purchase) · Derivative | 40,101 | $0.00 Strike: $34.91 | $0.00 |
DisclosureSEC source: 0001104659-25-024429 · tm259280-3_4seq1.xml · derivative · entry 4 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,141 Underlying: Common Stock · 40,141 shares Expires 2035-03-13 F3 · derivative.exercise_date: The option to purchase shares of the Issuer's Common Stock was granted under the Plan. Options to purchase 13,367 shares of the Issuer's Common Stock will vest and become exercisable on each of March 13, 2026, March 13, 2027 and March 13, 2028, respectively. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:16 UTC |
Browers BlaineCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 3,393 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-024429 · tm259280-3_4seq1.xml · derivative · entry 3 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,393 Underlying: Common Stock · 3,393 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Comprised of a restricted stock units award previously granted on March 13, 2023 (the "Restricted Stock Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 10,177 restricted shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 3,391 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2024, 3,393 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2025, and 3,393 restricted shares of Common Stock will vest and become non-forfeitable on March 13, 2026. F1 · derivative.exercise_date: Comprised of a restricted stock units award previously granted on March 13, 2023 (the "Restricted Stock Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 10,177 restricted shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 3,391 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2024, 3,393 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2025, and 3,393 restricted shares of Common Stock will vest and become non-forfeitable on March 13, 2026. F1 · derivative.expiration_date: Comprised of a restricted stock units award previously granted on March 13, 2023 (the "Restricted Stock Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 10,177 restricted shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 3,391 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2024, 3,393 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2025, and 3,393 restricted shares of Common Stock will vest and become non-forfeitable on March 13, 2026. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:16 UTC |
Browers BlaineCHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 826 | $34.91 | $28,835.66 |
DisclosureSEC source: 0001104659-25-024429 · tm259280-3_4seq1.xml · nonDerivative · entry 2 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,096 F2 · shares: Represents the number of shares of Common Stock withheld by the Issuer to satisfy the tax withholding obligations incurred by Mr. Browers as a result of the vesting on March 13, 2025, of a portion of the Restricted Stock Award. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 20:16 UTC |
Browers BlaineCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock, par value $0.0001 per share ("Common Stock") | 3,393 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-024429 · tm259280-3_4seq1.xml · nonDerivative · entry 1 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,922 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Comprised of a restricted stock units award previously granted on March 13, 2023 (the "Restricted Stock Award"), under the Issuer's 2021 Stock Incentive Plan (the "Plan") consisting of 10,177 restricted shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). 3,391 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2024, 3,393 restricted shares of Common Stock vested and became non-forfeitable on March 13, 2025, and 3,393 restricted shares of Common Stock will vest and become non-forfeitable on March 13, 2026. Read SEC document |
| March 13, 2025 Filed Apr 24, 2025 20:45 UTC Amendment |
KANDERS WARREN BDirector · CEO AND CHAIRMAN · 10% owner
|
GrantRestricted Stock Units · Derivative | 37,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-038713 · tm2513047-1_4aseq1.xml · derivative · entry 2 KANDERS WARREN B · CIK 0000935577 · Director · CEO AND CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,666 Underlying: Common Stock · 37,666 shares Expires not disclosed F2 · derivative.exercise_price: Comprised of a restricted stock units award granted under the Plan consisting of 37,666 restricted shares of the Issuer's Common Stock. 12,556 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2026, and 12,555 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 13, 2027, and March 13, 2028, respectively. F3 · derivative.exercise_price: This amendment is being filed to correct the number of options and restricted stock units granted on March 13, 2025 and reported in the original Form 4 filed on March 17, 2025. Footnotes 6 and 7 have been renumbered and revised accordingly. F2 · derivative.exercise_date: Comprised of a restricted stock units award granted under the Plan consisting of 37,666 restricted shares of the Issuer's Common Stock. 12,556 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2026, and 12,555 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 13, 2027, and March 13, 2028, respectively. F3 · derivative.exercise_date: This amendment is being filed to correct the number of options and restricted stock units granted on March 13, 2025 and reported in the original Form 4 filed on March 17, 2025. Footnotes 6 and 7 have been renumbered and revised accordingly. F2 · derivative.expiration_date: Comprised of a restricted stock units award granted under the Plan consisting of 37,666 restricted shares of the Issuer's Common Stock. 12,556 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2026, and 12,555 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 13, 2027, and March 13, 2028, respectively. F3 · derivative.expiration_date: This amendment is being filed to correct the number of options and restricted stock units granted on March 13, 2025 and reported in the original Form 4 filed on March 17, 2025. Footnotes 6 and 7 have been renumbered and revised accordingly. Read SEC document |
| March 13, 2025 Filed Apr 24, 2025 20:45 UTC Amendment |
KANDERS WARREN BDirector · CEO AND CHAIRMAN · 10% owner
|
GrantStock Option (right to purchase) · Derivative | 117,457 | $0.00 Strike: $33.85 | $0.00 |
DisclosureSEC source: 0001104659-25-038713 · tm2513047-1_4aseq1.xml · derivative · entry 1 KANDERS WARREN B · CIK 0000935577 · Director · CEO AND CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,457 Underlying: Common Stock · 117,457 shares Expires 2035-03-13 F1 · derivative.exercise_date: The option to purchase 117,457 shares of the Issuer's Common Stock, par value $0.0001 per share ("Common Stock"), was granted under the Plan. Options to purchase 39,153 shares of the Issuer's Common Stock will vest and become exercisable on March 13, 2026, and options to purchase 39,152 shares of the Issuer's Common Stock will vest and become exercisable on each of March 13, 2027, and March 13, 2028, respectively. F3 · derivative.exercise_date: This amendment is being filed to correct the number of options and restricted stock units granted on March 13, 2025 and reported in the original Form 4 filed on March 17, 2025. Footnotes 6 and 7 have been renumbered and revised accordingly. Read SEC document |
| March 13, 2025 Filed Apr 24, 2025 20:45 UTC Amendment |
Williams BradPRESIDENT
|
GrantRestricted Stock Units · Derivative | 15,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-038715 · tm2513047-2_4aseq1.xml · derivative · entry 2 Williams Brad · CIK 0001876053 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,510 Underlying: Common Stock · 15,510 shares Expires not disclosed F2 · derivative.exercise_price: Comprised of a restricted stock units award granted under the Plan consisting of 15,510 restricted shares of the Issuer's Common Stock. 5,170 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 13, 2026, March 13, 2027 and March 13, 2028, respectively. F3 · derivative.exercise_price: This amendment is being filed to correct the number of options and restricted stock units granted on March 13, 2025 and reported in the original Form 4 filed on March 17, 2025. Footnotes 3 and 4 have been renumbered and revised accordingly. F2 · derivative.exercise_date: Comprised of a restricted stock units award granted under the Plan consisting of 15,510 restricted shares of the Issuer's Common Stock. 5,170 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 13, 2026, March 13, 2027 and March 13, 2028, respectively. F3 · derivative.exercise_date: This amendment is being filed to correct the number of options and restricted stock units granted on March 13, 2025 and reported in the original Form 4 filed on March 17, 2025. Footnotes 3 and 4 have been renumbered and revised accordingly. F2 · derivative.expiration_date: Comprised of a restricted stock units award granted under the Plan consisting of 15,510 restricted shares of the Issuer's Common Stock. 5,170 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on each of March 13, 2026, March 13, 2027 and March 13, 2028, respectively. F3 · derivative.expiration_date: This amendment is being filed to correct the number of options and restricted stock units granted on March 13, 2025 and reported in the original Form 4 filed on March 17, 2025. Footnotes 3 and 4 have been renumbered and revised accordingly. Read SEC document |
| March 13, 2025 Filed Apr 24, 2025 20:45 UTC Amendment |
Williams BradPRESIDENT
|
GrantStock Option (right to purchase) · Derivative | 48,365 | $0.00 Strike: $33.85 | $0.00 |
DisclosureSEC source: 0001104659-25-038715 · tm2513047-2_4aseq1.xml · derivative · entry 1 Williams Brad · CIK 0001876053 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,365 Underlying: Common Stock · 48,365 shares Expires 2035-03-13 F1 · derivative.exercise_date: The option to purchase 48,365 shares of the Issuer's Common Stock, par value $0.0001 per share ("Common Stock"), was granted under the Plan. Options to purchase 16,121 shares of the Issuer's Common Stock will vest and become exercisable on March 13, 2026, and options to purchase 16,122 shares of the Issuer's Common Stock will vest and become exercisable on each of March 13, 2027, and March 13, 2028, respectively. F3 · derivative.exercise_date: This amendment is being filed to correct the number of options and restricted stock units granted on March 13, 2025 and reported in the original Form 4 filed on March 17, 2025. Footnotes 3 and 4 have been renumbered and revised accordingly. Read SEC document |
| March 13, 2025 Filed Apr 24, 2025 20:47 UTC Amendment |
Browers BlaineCHIEF FINANCIAL OFFICER
|
GrantRestricted Stock Units · Derivative | 12,925 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-038720 · tm2513047-3_4aseq1.xml · derivative · entry 2 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,925 Underlying: Common Stock · 12,925 shares Expires not disclosed F2 · derivative.exercise_price: Comprised of a restricted stock units award granted under the Plan consisting of 12,925 restricted shares of the Issuer's Common Stock. 4,309 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2026, and 4,308 restricted shares of the Issuer's Common will vest and become non-forfeitable on each if March 13, 2027 and March 13, 2028, respectively. F3 · derivative.exercise_price: This amendment is being filed to correct the number of options and restricted stock units granted on March 13, 2025 and reported in the original Form 4 filed on March 17, 2025. Footnotes 3 and 4 have been renumbered and revised accordingly. F2 · derivative.exercise_date: Comprised of a restricted stock units award granted under the Plan consisting of 12,925 restricted shares of the Issuer's Common Stock. 4,309 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2026, and 4,308 restricted shares of the Issuer's Common will vest and become non-forfeitable on each if March 13, 2027 and March 13, 2028, respectively. F3 · derivative.exercise_date: This amendment is being filed to correct the number of options and restricted stock units granted on March 13, 2025 and reported in the original Form 4 filed on March 17, 2025. Footnotes 3 and 4 have been renumbered and revised accordingly. F2 · derivative.expiration_date: Comprised of a restricted stock units award granted under the Plan consisting of 12,925 restricted shares of the Issuer's Common Stock. 4,309 restricted shares of the Issuer's Common Stock will vest and become non-forfeitable on March 13, 2026, and 4,308 restricted shares of the Issuer's Common will vest and become non-forfeitable on each if March 13, 2027 and March 13, 2028, respectively. F3 · derivative.expiration_date: This amendment is being filed to correct the number of options and restricted stock units granted on March 13, 2025 and reported in the original Form 4 filed on March 17, 2025. Footnotes 3 and 4 have been renumbered and revised accordingly. Read SEC document |
| March 13, 2025 Filed Apr 24, 2025 20:47 UTC Amendment |
Browers BlaineCHIEF FINANCIAL OFFICER
|
GrantStock Option (right to purchase) · Derivative | 40,304 | $0.00 Strike: $33.85 | $0.00 |
DisclosureSEC source: 0001104659-25-038720 · tm2513047-3_4aseq1.xml · derivative · entry 1 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,304 Underlying: Common Stock · 40,304 shares Expires 2035-03-13 F1 · derivative.exercise_date: The option to purchase 40,304 shares of the Issuer's Common Stock, par value $0.0001 per share ("Common Stock"), was granted under the Plan. Options to purchase 13,434 shares of the Issuer's Common Stock will vest and become exercisable on March 13, 2026, and options to purchase 13,435 shares of the Issuer's Common Stock will vest and become exercisable on each of March 13, 2027, and March 13, 2028, respectively. F3 · derivative.exercise_date: This amendment is being filed to correct the number of options and restricted stock units granted on March 13, 2025 and reported in the original Form 4 filed on March 17, 2025. Footnotes 3 and 4 have been renumbered and revised accordingly. Read SEC document |
| March 09, 2025 Filed Mar 11, 2025 20:15 UTC |
KANDERS WARREN BDirector · CEO AND CHAIRMAN · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 10,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-022563 · tm258792-1_4seq1.xml · derivative · entry 6 KANDERS WARREN B · CIK 0000935577 · Director · CEO AND CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Comprised of a restricted stock units award previously granted on March 9, 2022, under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 31,250 restricted shares of Common Stock. 10,416, 10,417 and 10,417 restricted shares of Common Stock vested and became non-forfeitable on each of March 9, 2023, March 9, 2024, and March 9, 2025, respectively. F1 · derivative.exercise_date: Comprised of a restricted stock units award previously granted on March 9, 2022, under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 31,250 restricted shares of Common Stock. 10,416, 10,417 and 10,417 restricted shares of Common Stock vested and became non-forfeitable on each of March 9, 2023, March 9, 2024, and March 9, 2025, respectively. F1 · derivative.expiration_date: Comprised of a restricted stock units award previously granted on March 9, 2022, under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 31,250 restricted shares of Common Stock. 10,416, 10,417 and 10,417 restricted shares of Common Stock vested and became non-forfeitable on each of March 9, 2023, March 9, 2024, and March 9, 2025, respectively. Read SEC document |
| March 09, 2025 Filed Mar 11, 2025 20:15 UTC |
KANDERS WARREN BDirector · CEO AND CHAIRMAN · 10% owner
|
Tax withholdingCommon Stock | 4,099 | $34.02 | $139,447.98 |
DisclosureSEC source: 0001104659-25-022563 · tm258792-1_4seq1.xml · nonDerivative · entry 2 KANDERS WARREN B · CIK 0000935577 · Director · CEO AND CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,310 F2 · shares: Represents the number of shares of Common Stock withheld by the Issuer to satisfy the tax withholding obligations incurred by Mr. Kanders as a result of the vesting on March 9, 2025, of a portion of the Restricted Stock Award. Read SEC document |
| March 09, 2025 Filed Mar 11, 2025 20:15 UTC |
KANDERS WARREN BDirector · CEO AND CHAIRMAN · 10% owner
|
Exercise / conversionCommon Stock, par value $0.0001 per share ("Common Stock") | 10,417 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-022563 · tm258792-1_4seq1.xml · nonDerivative · entry 1 KANDERS WARREN B · CIK 0000935577 · Director · CEO AND CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,409 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Comprised of a restricted stock units award previously granted on March 9, 2022, under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 31,250 restricted shares of Common Stock. 10,416, 10,417 and 10,417 restricted shares of Common Stock vested and became non-forfeitable on each of March 9, 2023, March 9, 2024, and March 9, 2025, respectively. Read SEC document |
| March 09, 2025 Filed Mar 11, 2025 20:15 UTC |
Williams BradPRESIDENT
|
Exercise / conversionRestricted Stock Units · Derivative | 3,921 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-022566 · tm258792-2_4seq1.xml · derivative · entry 3 Williams Brad · CIK 0001876053 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,921 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Comprised of a restricted stock units award previously granted on March 9, 2022, under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 11,762 restricted shares of Common Stock. 3,920, 3,921 and 3,921 restricted shares of Common Stock vested and became non-forfeitable on each of March 9, 2023, March 9, 2024, and March 9, 2025, respectively. F1 · derivative.exercise_date: Comprised of a restricted stock units award previously granted on March 9, 2022, under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 11,762 restricted shares of Common Stock. 3,920, 3,921 and 3,921 restricted shares of Common Stock vested and became non-forfeitable on each of March 9, 2023, March 9, 2024, and March 9, 2025, respectively. F1 · derivative.expiration_date: Comprised of a restricted stock units award previously granted on March 9, 2022, under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 11,762 restricted shares of Common Stock. 3,920, 3,921 and 3,921 restricted shares of Common Stock vested and became non-forfeitable on each of March 9, 2023, March 9, 2024, and March 9, 2025, respectively. Read SEC document |
| March 09, 2025 Filed Mar 11, 2025 20:15 UTC |
Williams BradPRESIDENT
|
Tax withholdingCommon Stock | 1,629 | $34.02 | $55,418.58 |
DisclosureSEC source: 0001104659-25-022566 · tm258792-2_4seq1.xml · nonDerivative · entry 2 Williams Brad · CIK 0001876053 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,210 F2 · shares: Represents the number of shares of Common Stock withheld by the Issuer to satisfy the tax withholding obligations incurred by Mr. Williams as a result of the vesting on March 9, 2025, of a portion of the Restricted Stock Award. Read SEC document |
| March 09, 2025 Filed Mar 11, 2025 20:15 UTC |
Williams BradPRESIDENT
|
Exercise / conversionCommon Stock, par value $0.0001 per share ("Common Stock") | 3,921 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-022566 · tm258792-2_4seq1.xml · nonDerivative · entry 1 Williams Brad · CIK 0001876053 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,839 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Comprised of a restricted stock units award previously granted on March 9, 2022, under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 11,762 restricted shares of Common Stock. 3,920, 3,921 and 3,921 restricted shares of Common Stock vested and became non-forfeitable on each of March 9, 2023, March 9, 2024, and March 9, 2025, respectively. Read SEC document |
| March 09, 2025 Filed Mar 11, 2025 20:15 UTC |
Browers BlaineCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 2,918 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-022568 · tm258792-3_4seq1.xml · derivative · entry 3 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,918 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Comprised of a restricted stock units award previously granted on March 9, 2022, under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 8,755 restricted shares of Common Stock. 2,919, 2,918 and 2,918 restricted shares of Common Stock vested and became non-forfeitable on each of March 9, 2023, March 9, 2024, and March 9, 2025, respectively. F1 · derivative.exercise_date: Comprised of a restricted stock units award previously granted on March 9, 2022, under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 8,755 restricted shares of Common Stock. 2,919, 2,918 and 2,918 restricted shares of Common Stock vested and became non-forfeitable on each of March 9, 2023, March 9, 2024, and March 9, 2025, respectively. F1 · derivative.expiration_date: Comprised of a restricted stock units award previously granted on March 9, 2022, under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 8,755 restricted shares of Common Stock. 2,919, 2,918 and 2,918 restricted shares of Common Stock vested and became non-forfeitable on each of March 9, 2023, March 9, 2024, and March 9, 2025, respectively. Read SEC document |
| March 09, 2025 Filed Mar 11, 2025 20:15 UTC |
Browers BlaineCHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 1,265 | $34.02 | $43,035.30 |
DisclosureSEC source: 0001104659-25-022568 · tm258792-3_4seq1.xml · nonDerivative · entry 2 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,529 F2 · shares: Represents the number of shares of Common Stock withheld by the Issuer to satisfy the tax withholding obligations incurred by Mr. Browers as a result of the vesting on March 9, 2025, of a portion of the Restricted Stock Award. Read SEC document |
| March 09, 2025 Filed Mar 11, 2025 20:15 UTC |
Browers BlaineCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock, par value $0.0001 per share ("Common Stock") | 2,918 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-25-022568 · tm258792-3_4seq1.xml · nonDerivative · entry 1 Browers Blaine · CIK 0001874169 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,794 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Comprised of a restricted stock units award previously granted on March 9, 2022, under the Issuer's 2021 Stock Incentive Plan (the "Restricted Stock Award") consisting of 8,755 restricted shares of Common Stock. 2,919, 2,918 and 2,918 restricted shares of Common Stock vested and became non-forfeitable on each of March 9, 2023, March 9, 2024, and March 9, 2025, respectively. Read SEC document |
| December 30, 2024 Filed Jan 2, 2025 21:15 UTC |
KANDERS WARREN BDirector · CEO AND CHAIRMAN · 10% owner
|
GiftCommon Stock, par value $0.0001 per share ("Common Stock") | 128,886 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-000326 · tm251646-1_4seq1.xml · nonDerivative · entry 1 KANDERS WARREN B · CIK 0000935577 · Director · CEO AND CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Kanders SAF, LLC Disclosed balance after: 11,266,192 F1 · price: This transaction involved gifts of shares of Common Stock by the Reporting Person to two qualified charitable organizations. F2 · ownership.nature: The Reporting Person is the sole manager and member of Kanders SAF, LLC. F4 · ownership.nature: The Reporting Person disclaims beneficial ownership of the securities described in this statement, except to the extent of his pecuniary interest in such securities. Read SEC document |
| December 16, 2024 Filed Dec 18, 2024 21:15 UTC |
KANDERS WARREN BDirector · CEO AND CHAIRMAN · 10% owner
|
SaleCommon Stock, par value $0.0001 per share ("Common Stock") | 12,133 | $36.22 | $439,457.26 |
DisclosureSEC source: 0001104659-24-129763 · tm2431366-1_4seq1.xml · nonDerivative · entry 1 KANDERS WARREN B · CIK 0000935577 · Director · CEO AND CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Kanders SAF, LLC Disclosed balance after: 11,395,078 F1 · price: The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $35.96 - $36.40 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. F2 · ownership.nature: The Reporting Person is the sole manager and member of Kanders SAF, LLC. F4 · ownership.nature: The Reporting Person disclaims beneficial ownership of the securities described in this statement, except to the extent of his pecuniary interest in such securities. Read SEC document |
| December 13, 2024 Filed Dec 16, 2024 21:15 UTC |
KANDERS WARREN BDirector · CEO AND CHAIRMAN · 10% owner
|
SaleCommon Stock, par value $0.0001 per share ("Common Stock") | 25,000 | $35.29 | $882,250.00 |
DisclosureSEC source: 0001104659-24-128904 · tm2431107-1_4seq1.xml · nonDerivative · entry 1 KANDERS WARREN B · CIK 0000935577 · Director · CEO AND CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Kanders SAF, LLC Disclosed balance after: 11,407,211 F1 · price: The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $35.01 - $35.67 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. F2 · ownership.nature: The Reporting Person is the sole manager and member of Kanders SAF, LLC. F4 · ownership.nature: The Reporting Person disclaims beneficial ownership of the securities described in this statement, except to the extent of his pecuniary interest in such securities. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 21:15 UTC |
KANDERS WARREN BDirector · CEO AND CHAIRMAN · 10% owner
|
SaleCommon Stock, par value $0.0001 per share ("Common Stock") | 25,000 | $35.32 | $883,000.00 |
DisclosureSEC source: 0001104659-24-128432 · tm2431045-1_4seq1.xml · nonDerivative · entry 1 KANDERS WARREN B · CIK 0000935577 · Director · CEO AND CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Kanders SAF, LLC Disclosed balance after: 11,432,211 F1 · price: The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $35.12 - $35.53 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. F2 · ownership.nature: The Reporting Person is the sole manager and member of Kanders SAF, LLC. F4 · ownership.nature: The Reporting Person disclaims beneficial ownership of the securities described in this statement, except to the extent of his pecuniary interest in such securities. Read SEC document |
| December 10, 2024 Filed Dec 11, 2024 21:15 UTC |
KANDERS WARREN BDirector · CEO AND CHAIRMAN · 10% owner
|
SaleCommon Stock | 25,000 | $35.05 | $876,250.00 |
DisclosureSEC source: 0001104659-24-127618 · tm2430776-1_4seq1.xml · nonDerivative · entry 2 KANDERS WARREN B · CIK 0000935577 · Director · CEO AND CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Kanders SAF, LLC Disclosed balance after: 11,457,211 F2 · price: The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $35.00 - $35.35 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · ownership.nature: The Reporting Person is the sole manager and member of Kanders SAF, LLC. F5 · ownership.nature: The Reporting Person disclaims beneficial ownership of the securities described in this statement, except to the extent of his pecuniary interest in such securities. Read SEC document |
| December 09, 2024 Filed Dec 11, 2024 21:15 UTC |
KANDERS WARREN BDirector · CEO AND CHAIRMAN · 10% owner
|
SaleCommon Stock, par value $0.0001 per share ("Common Stock") | 25,000 | $35.49 | $887,250.00 |
DisclosureSEC source: 0001104659-24-127618 · tm2430776-1_4seq1.xml · nonDerivative · entry 1 KANDERS WARREN B · CIK 0000935577 · Director · CEO AND CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Kanders SAF, LLC Disclosed balance after: 11,482,211 F1 · price: The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $35.26 - $35.90 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. F3 · ownership.nature: The Reporting Person is the sole manager and member of Kanders SAF, LLC. F5 · ownership.nature: The Reporting Person disclaims beneficial ownership of the securities described in this statement, except to the extent of his pecuniary interest in such securities. Read SEC document |
| December 06, 2024 Filed Dec 9, 2024 21:15 UTC |
KANDERS WARREN BDirector · CEO AND CHAIRMAN · 10% owner
|
SaleCommon Stock | 25,000 | $35.67 | $891,750.00 |
DisclosureSEC source: 0001104659-24-126757 · tm2430523-1_4seq1.xml · nonDerivative · entry 2 KANDERS WARREN B · CIK 0000935577 · Director · CEO AND CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Kanders SAF, LLC Disclosed balance after: 11,507,211 F2 · price: The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $35.02 - $36.02 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · ownership.nature: The Reporting Person is the sole manager and member of Kanders SAF, LLC. F5 · ownership.nature: The Reporting Person disclaims beneficial ownership of the securities described in this statement, except to the extent of his pecuniary interest in such securities. Read SEC document |
| December 05, 2024 Filed Dec 9, 2024 21:15 UTC |
KANDERS WARREN BDirector · CEO AND CHAIRMAN · 10% owner
|
SaleCommon Stock, par value $0.0001 per share ("Common Stock") | 25,000 | $35.83 | $895,750.00 |
DisclosureSEC source: 0001104659-24-126757 · tm2430523-1_4seq1.xml · nonDerivative · entry 1 KANDERS WARREN B · CIK 0000935577 · Director · CEO AND CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Kanders SAF, LLC Disclosed balance after: 11,532,211 F1 · price: The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $35.68 - $35.92 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. F3 · ownership.nature: The Reporting Person is the sole manager and member of Kanders SAF, LLC. F5 · ownership.nature: The Reporting Person disclaims beneficial ownership of the securities described in this statement, except to the extent of his pecuniary interest in such securities. Read SEC document |
| December 03, 2024 Filed Dec 3, 2024 21:15 UTC |
SOKOLOW NICOLASDirector
|
SaleCommon Stock | 3,154 | $34.08 | $107,486.11 |
DisclosureSEC source: 0001104659-24-125080 · tm2429899-2_4seq1.xml · nonDerivative · entry 5 SOKOLOW NICOLAS · CIK 0001027431 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 79,231 F5 · price: The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $34.05 - $34.09 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (5) to this Form 4. F2 · ownership.nature: The securities reported herein are owned by Madetys Investments, LLC, a limited liability company of which the Reporting Person is the general manager. F7 · ownership.nature: The Reporting Person disclaims beneficial ownership of the securities described in this statement, except to the extent of his pecuniary interest in such securities. Read SEC document |
| December 03, 2024 Filed Dec 3, 2024 21:15 UTC |
SOKOLOW NICOLASDirector
|
SaleCommon Stock | 4,089 | $34.08 | $139,352.30 |
DisclosureSEC source: 0001104659-24-125080 · tm2429899-2_4seq1.xml · nonDerivative · entry 4 SOKOLOW NICOLAS · CIK 0001027431 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 467,620 F4 · price: The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $34.07 - $34.09 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (4) to this Form 4. F1 · ownership.nature: The securities reported herein are owned by ST Investors Fund, LLC, a limited liability company of which the Reporting Person is its secretary and treasurer. F7 · ownership.nature: The Reporting Person disclaims beneficial ownership of the securities described in this statement, except to the extent of his pecuniary interest in such securities. Read SEC document |
| December 03, 2024 Filed Dec 4, 2024 21:15 UTC |
KANDERS WARREN BDirector · CEO AND CHAIRMAN · 10% owner
|
SaleCommon Stock | 50,000 | $34.24 | $1,712,000.00 |
DisclosureSEC source: 0001104659-24-125524 · tm2430113-1_4seq1.xml · nonDerivative · entry 2 KANDERS WARREN B · CIK 0000935577 · Director · CEO AND CHAIRMAN · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Kanders SAF, LLC Disclosed balance after: 11,557,211 F2 · price: The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $33.77 - $34.87 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (2) to this Form 4. F3 · ownership.nature: The Reporting Person is the sole manager and member of Kanders SAF, LLC. F5 · ownership.nature: The Reporting Person disclaims beneficial ownership of the securities described in this statement, except to the extent of his pecuniary interest in such securities. Read SEC document |
| December 03, 2024 Filed Dec 5, 2024 21:15 UTC |
Williams BradPRESIDENT
|
SaleCommon Stock, par value $0.0001 per share ("Common Stock") | 25,000 | $34.24 | $856,000.00 |
DisclosureSEC source: 0001104659-24-125906 · tm2430277-1_4seq1.xml · nonDerivative · entry 1 Williams Brad · CIK 0001876053 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,918 F1 · price: The price reported in Column 4 is a weighted average price per share. These shares of Common Stock were sold in multiple transactions at prices ranging from $34.20 - $34.50 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (1) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.